Spirodin-M Tablet SR
By Spirodin-M
Rx
10 Tablet SR in a Strip

Composition
Doxofylline(400mg) + Montelukast(10mg)

Manufacturer - Koye Pharmaceuticals Pvt ltd
A-10, 3rd Floor, Art Guild House, Phoenix Market City Annexe, LBS Marg, Kurla (West), Mumbai - 400070

Expires on or after
March, 2027

liver
When using Spirodin-M Tablet SR, it is important to be cautious if you have severe liver disease. In such cases, a dose adjustment of Spirodin-M Tablet SR may be necessary. It is crucial to consult your doctor before taking this medication if you have severe liver issues. Limited data is available on the use of Spirodin-M Tablet SR in patients with severe liver disease, so it is essential to seek guidance from your healthcare provider. However, no dose adjustment is typically needed for patients with mild to moderate liver disease. Remember, always consult with your doctor for proper guidance before using Spirodin-M Tablet SR.

kidney
Consult with your doctor for proper guidance before using Spirodin-M Tablet SR in patients with kidney disease due to limited available information.

alcohol
Caution is advised when consuming alcohol with Spirodin-M Tablet SR. Consult your doctor when using this medication.

driving
When taking Spirodin-M Tablet SR, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
It is better to consult your doctor before using Spirodin-M Tablet SR during pregnancy.

breastfeeding
Spirodin-M Tablet SR is likely safe for breastfeeding, based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹178
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024